Details
Title
Author Correction: Diversity-oriented synthesis encoded by deoxyoligonucleotides
Author
Hudson, Liam 1
; Mason, Jeremy W. 1 ; Westphal, Matthias V. 1
; Richter, Matthieu J. R. 2 ; Thielman, Jonathan R. 2
; Hua, Bruce K. 2
; Gerry, Christopher J. 2
; Xia, Guoqin 3
; Osswald, Heather L. 3 ; Knapp, John M. 2 ; Tan, Zher Yin 2 ; Kokkonda, Praveen 2 ; Tresco, Ben I. C. 2 ; Liu, Shuang 4
; Reidenbach, Andrew G. 2 ; Lim, Katherine S. 2
; Poirier, Jennifer 5 ; Capece, John 5 ; Bonazzi, Simone 5 ; Gampe, Christian M. 5 ; Smith, Nichola J. 5
; Bradner, James E. 5
; Coley, Connor W. 6
; Clemons, Paul A. 2
; Melillo, Bruno 3
; Hon, C. Suk-Yee 2 ; Ottl, Johannes 7 ; Dumelin, Christoph E. 7 ; Schaefer, Jonas V. 7
; Faust, Ann Marie E. 5
; Berst, Frédéric 7 ; Schreiber, Stuart L. 4
; Zécri, Frédéric J. 5
; Briner, Karin 5
1 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.492505.f)
2 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34)
3 The Scripps Research Institute, Department of Chemistry, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000 0001 2219 9231)
4 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); Harvard University, Department of Chemistry and Chemical Biology, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
5 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.492505.f)
6 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); MIT, Department of Chemical Engineering, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
7 Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus, Basel, Switzerland (GRID:grid.419481.1) (ISNI:0000 0001 1515 9979)
; Mason, Jeremy W. 1 ; Westphal, Matthias V. 1
; Richter, Matthieu J. R. 2 ; Thielman, Jonathan R. 2
; Hua, Bruce K. 2
; Gerry, Christopher J. 2
; Xia, Guoqin 3
; Osswald, Heather L. 3 ; Knapp, John M. 2 ; Tan, Zher Yin 2 ; Kokkonda, Praveen 2 ; Tresco, Ben I. C. 2 ; Liu, Shuang 4
; Reidenbach, Andrew G. 2 ; Lim, Katherine S. 2
; Poirier, Jennifer 5 ; Capece, John 5 ; Bonazzi, Simone 5 ; Gampe, Christian M. 5 ; Smith, Nichola J. 5
; Bradner, James E. 5
; Coley, Connor W. 6
; Clemons, Paul A. 2
; Melillo, Bruno 3
; Hon, C. Suk-Yee 2 ; Ottl, Johannes 7 ; Dumelin, Christoph E. 7 ; Schaefer, Jonas V. 7
; Faust, Ann Marie E. 5
; Berst, Frédéric 7 ; Schreiber, Stuart L. 4
; Zécri, Frédéric J. 5
; Briner, Karin 5 1 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.492505.f)
2 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34)
3 The Scripps Research Institute, Department of Chemistry, La Jolla, USA (GRID:grid.214007.0) (ISNI:0000 0001 2219 9231)
4 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); Harvard University, Department of Chemistry and Chemical Biology, Cambridge, USA (GRID:grid.38142.3c) (ISNI:0000 0004 1936 754X)
5 Novartis Institutes for BioMedical Research, Cambridge, USA (GRID:grid.492505.f)
6 Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA (GRID:grid.66859.34); MIT, Department of Chemical Engineering, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786)
7 Novartis Institutes for BioMedical Research, Novartis Pharma AG, Novartis Campus, Basel, Switzerland (GRID:grid.419481.1) (ISNI:0000 0001 1515 9979)
Pages
7589
Publication year
2023
Publication date
2023
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2892156945
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.